نتائج البحث - "Emile E. Voest"

المصدر: Vis, D J, Lewin, J, Liao, R G, Mao, M, Andre, F, Ward, R L, Calvo, F, Teh, B T, Camargo, A A, Knoppers, B M, Sawyers, C L, Wessels, L F A, Lawler, M, Siu, L L, Voest, E & Clinical Working Group of the Global Alliance for Genomics and Health 2017, ' Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape ' Annals of Oncology, vol. 28, no. 5, pp. 1145-1151 . DOI: 10.1093/annonc/mdx037
Annals of Oncology

مصطلحات موضوعية: 0301 basic medicine, Knowledge management, molecular profiling, data sharing, DNA Mutational Analysis, Automatic identification and data capture, Genomics, Harmonization, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Surveys and Questionnaires, Databases, Genetic, Exome Sequencing, genomics, Journal Article, cancer, Humans, Medicine, survey, Genetic Predisposition to Disease, Precision Medicine, Genetic Association Studies, Exome sequencing, Whole genome sequencing, Data collection, Genome, Human, business.industry, Molecular Sequence Annotation, Original Articles, Hematology, 3. Good health, Biotechnology, Data sharing, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business, Raw data

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b1e22c1a03d2f34a256a878011aaa84Test
https://doi.org/10.1093/annonc/mdx037Test

6

Molecular Tumor Boards: current practice and future needs

المؤلفون: C.M.L. van Herpen, Emile E. Voest, Egbert F. Smit, Petra M. Nederlof, Edwin Cuppen, Marlies H.G. Langenberg, Harry J.M. Groen, Stefan M. Willems, H.W.M. van Laarhoven, Stefan Sleijfer, Neeltje Steeghs, D.L. van der Velden

المساهمون: Medical Oncology, VU University medical center, General practice, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA - Imaging and biomarkers, Oncology, CCA -Cancer Center Amsterdam

المصدر: Annals of Oncology, 28, 12, pp. 3070-3075
Annals of Oncology, 28(12), 3070-3075. Elsevier Ltd.
Annals of Oncology, 28(12), 3070. Oxford University Press
Annals of Oncology, 28(12), 3070-3075. Oxford University Press
Annals of oncology, 28(12), 3070-3075. Oxford University Press
Annals of Oncology, 28, 3070-3075

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Process management, UNIVERSITY-OF-CALIFORNIA, whole genome sequencing (WGS), media_common.quotation_subject, MULTICENTER, EXOME, Genetics-guided cancer care, Harmonization, Medical Oncology, Targeted therapy, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, LUNG-CANCER, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, genetics guided cancer care, Multidisciplinary approach, Neoplasms, Journal Article, Humans, BREAST-CANCER, Medicine, Quality (business), Genetic Testing, Netherlands, Genetic testing, media_common, Pace of innovation, Molecular Tumor Board, medicine.diagnostic_test, business.industry, Whole-genome sequencing (WGS), Hematology, CHEMOTHERAPY, Data sharing, 030104 developmental biology, Workflow, Oncology, MOORES CANCER CENTER, 030220 oncology & carcinogenesis, Family medicine, EXPERIENCE, Basic needs, business, GENOMICS, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: image/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ce05628ea99c9a39be1985ff25ccd2Test
https://doi.org/10.1093/annonc/mdx528Test

7

Drug Rediscovery Protocol: Expanded use of existing anticancer drugs

المصدر: Annals of Oncology. 30:v864-v865

مصطلحات موضوعية: medicine.medical_specialty, Oncology, business.industry, Precision oncology, Family medicine, Visual accommodation, Daily practice, Partial response, Medicine, Hematology, business, health care economics and organizations

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::211906d584897272d4f0008ea3801306Test
https://doi.org/10.1093/annonc/mdz394.016Test

8

Comprehensive pan-cancer analysis of somatic mutations in drug transporters to reveal acquired and intrinsic drug resistance in 3149 metastatic cancer patients

المؤلفون: H.J.G. Van de Werken, V.C.G. Tjan-Heijnen, J. van Riet, Henk M.W. Verheul, C.M.L. van Herpen, Edwin Cuppen, Neeltje Steeghs, Emile E. Voest, W.S. van de Geer, Martijn P. Lolkema, Stefan Sleijfer, Petronella O. Witteveen, Sander Bins, Ron H.J. Mathijssen

المصدر: Annals of Oncology. 30:v28-v29

مصطلحات موضوعية: Drug, Oncology, medicine.medical_specialty, biology, business.industry, media_common.quotation_subject, Cancer, Hematology, Drug resistance, medicine.disease, Clinical trial, Pharmacogenomics, Internal medicine, Cohort, biology.protein, Medicine, SLCO1B1, business, health care economics and organizations, Pharmacogenetics, media_common

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d2902bd30b402ab3170253ca056ba479Test
https://doi.org/10.1093/annonc/mdz239.011Test

9

Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

المؤلفون: L.R. Hoes, S B van Waalwijk van Doorn-Khosrovani, Stefan Sleijfer, Henk M.W. Verheul, W.H. van Harten, H. van der Wijngaart, A. D. R. Huitema, Emile E. Voest, J.M. van Berge Henegouwen, L. Timmers, M van der Graaff, J Gijzen, D.L. van der Velden, A. Pisters-van Roy, E. van Werkhoven, L. van Saase, Valesca P. Retèl, Hans Gelderblom

المساهمون: Health Technology & Services Research, Medical Oncology

المصدر: Annals of oncology, 30(5), 663-665. Oxford University Press
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 30(5), 663. Oxford University Press
Annals of Oncology, 30(5), 663-665
Annals of Oncology, 30, 663-665
Annals of Oncology, 30(5), 663-665. Elsevier Ltd.
van Waalwijk van Doorn-Khosrovani, S B, Pisters-van Roy, A, van Saase, L, van der Graaff, M, Gijzen, J, Sleijfer, S, Hoes, L R, van Berge Henegouwen, J M, van der Wijngaart, H, van der Velden, D L, van Werkhoven, E, Retel, V P, van Harten, W H, Huitema, A D R, Timmers, L, Gelderblom, H, Verheul, H M W & Voest, E E 2019, ' Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients ', Annals of Oncology, vol. 30, no. 5, pp. 663-665 . https://doi.org/10.1093/annonc/mdz119Test
Annals of Oncology, 30, 5, pp. 663-665

وصف الملف: application/pdf; image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14bb10cc3af9d34cae84a7503cc0401dTest
https://research.utwente.nl/en/publications/867aaee2-081a-47c1-8744-93881e853813Test

10

1594P Harmonising patient-access programmes

المؤلفون: Hans Gelderblom, Egbert F. Smit, P. Evers, Emile E. Voest, L. Timmers, S. Barjesteh Van Waalwijk Van Doorn-Khosrovani, L.J. Zeverijn, Haiko J. Bloemendal, Nicole M. A. Blijlevens, Thanh Huyen Tran, Ferry A.L.M. Eskens, Henk M.W. Verheul, L. van Saase, A. Pisters-van Roy

المصدر: Annals of Oncology. 31:S963

مصطلحات موضوعية: Oncology, Nursing, business.industry, Medicine, Hematology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3252da0a86db8f0f3fedba23fc6d9505Test
https://doi.org/10.1016/j.annonc.2020.08.1903Test

تنقيح النتائج